Update
21
Sep 22
Tasly U.S. to participate in BioJapan, October 10-14
Tasly U.S. will join with 11 other Maryland-based biopharmaceutical-focused organizations as an exhi…
15
Jul 22
What makes Tasly a great company to invest in?
If you’re interested in shaping the future of Western medicine by improving the quality of life for…
10
Jun 22
Cardiovascular (T89) Drug Updates
Tests show it can reduce chronic stable angina. Tasly Pharmaceuticals Inc(Tasly US), is nearing the…
Highlights
Cardiovascular (T89) Drug Clinical Studies
Dantonic® is a modern and industrialized botanical drug formula which features Danshen (Radix Salviae Miltiorrhizae, RSM) and Sanqi (Radix Notoginseng, RN) as active ingredients and Borneol as an absorption enhancer. Dantonic® was approved as a prescription drug for the treatment of chronic stable angina pectoris in patients with coronary heart disease by the State Food and Drug Administration of China (CFDA) in 1993. Learn more.